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Abstract
Alcoholic cirrhosis is frequently complicated by spontaneous bacterial peritonitis (SBP) due to the
translocation of gut bacteria. However, in immigrants to the USA from parts of the world with high
tuberculosis burden, a high degree of clinical suspicion of tuberculous peritonitis should be maintained
when a patient presents with symptoms similar to SBP. We describe a case of a 45-year-old Nepali man
with a history of alcohol abuse who immigrated to the USA six years prior and presented to the hospital
with abdominal pain, night sweats, fevers, and a 10 kg weight loss. A CT scan revealed abdominopelvic
ascites, liver nodularity suggestive of cirrhosis, and heterogeneous attenuation of the omentum. A CTguided biopsy of the omentum was done, and the histopathology revealed non-necrotizing granulomas.
However, given the demographics of the patient along with his constitutional symptoms, there was high
suspicion for abdominal tuberculosis, and a second CT-guided omental biopsy was done and sent for
tissue cultures. Due to the delay in getting microbiological confirmation of tuberculosis and persistent
fevers, an empiric trial of isoniazid, rifampicin, pyrazinamide, and ethambutol (RIPE) was started with
close monitoring of liver function tests. Since the patient’s symptoms improved, the RIPE regimen was
continued. Twenty-five days later, tuberculosis was confirmed on omental biopsy tissue culture. This case
highlights the diagnostic and treatment challenges associated with omental tuberculosis with liver
cirrhosis and suggests a potential role for an empiric trial of RIPE regimen in the appropriate clinical
context.
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Introduction
Liver cirrhosis is a state of immunosuppression and is an independent risk factor for the
development of tuberculous peritonitis by reactivating Mycobacterium tuberculosis from dormant
foci in the abdomen.1 It requires a strong clinical suspicion to diagnose tuberculous peritonitis as
the presenting symptoms may be non-specific and may mimic spontaneous bacterial peritonitis
with other common gut bacteria in patients with liver cirrhosis. Tuberculous peritonitis requires
many months of treatment which is sometimes riddled with complications of liver toxicity from
anti-tuberculous drugs. Unfortunately, there are no concrete guidelines to help direct therapy in
this discrete group of patients. This case aims to highlight the diagnostic and treatment challenges
associated with omental tuberculosis in a patient with alcoholic liver cirrhosis.
Case presentation
A 45-year-old Nepali man with a long-standing history of alcohol abuse presented to the hospital
with abdominal pain, bloating, night sweats, fevers, and a 10 kg unintentional weight loss within
the last few months. The abdominal pain was 7 out of 10 in intensity, localized to the right upper
quadrant, and aggravated by positional changes. The patient denied cough, sputum production,
difficulty breathing, or hemoptysis. On exam patient was febrile-101.3°F, tachycardic- 112 beats
per minute, along with abdominal distention, spider nevi, and scleral icterus. Initial lab workup
revealed a normal white cell count of 5.8 x10^9/L, hemoglobin of 14.4 g/dL, and mild
thrombocytopenia with platelet count of 148 x10^9/L. Basic metabolic panel were within normal
limits. Liver function tests showed elevated aspartate transaminase level of 86 U/L, normal alanine
transaminase of 29 U/L, elevated alkaline phosphatase of 167 U/L, elevated total bilirubin of 2.8
mg/dL with a direct bilirubin of 1.5 mg/dL, and low albumin level of 2.7 g/L. INR was moderately
elevated at 1.6. Hepatitis panel, HIV, and syphilis screening were negative. An abdominal CT scan
revealed liver nodularity suggesting cirrhosis and heterogeneous attenuation of the omentum and
mesentery with moderate ascites. However, no evidence of bowel wall thickening,
lymphadenopathy, or masses were seen. Ultrasound-guided paracentesis yielded 3 liters of hazy
fluid with 3011 nucleated cells with predominantly lymphocytes on analysis and no malignant
cells. Patient was admitted for management of suspected spontaneous bacterial peritonitis (SBP)
and was started on empiric therapy with Ampicillin/Sulbactam. Ascitic fluid culture, Gram stain,
and Acid-fast bacilli (AFB) stains were all negative, and the patient continued to spike fevers,
prompting broadening of antimicrobial therapy to Piperacillin/Tazobactam and Fluconazole. He
then underwent a CT-guided biopsy of the omentum which was sent for pathology, revealing nonnecrotizing granulomatous inflammation and giant cells, with negative Gram, AFB, and fungal
stains (Figure 1). However, the morphology of the granulomas was somewhat suggestive of an
infective etiology like tuberculosis, per pathology report. Keeping in mind that the patient was an
immigrant from Nepal with persistent fevers, night sweats, and abdominal tenderness, tuberculous
peritonitis was suspected, and antibiotics were discontinued. Unfortunately, the first time, omental
tissue biopsy cultures were not obtained. Given the potential hepatotoxicity of many antituberculous drugs like rifampicin, isoniazid, and pyrazinamide in the context of the patient’s liver
cirrhosis, confirmatory omental tissue cultures were recommended prior to initiate treatment for
tuberculous peritonitis. A second CT-guided biopsy was performed and sent for tissue cultures and
polymerase chain reaction (PCR) testing. The patient continued to remain febrile and weak, and
the team of physicians decided to try an empiric trial of rifampicin, isoniazid, pyrazinamide, and
ethambutol (RIPE) with close monitoring of liver function tests. Five days after starting treatment,

Published by RocScholar, 2021

1

Advances in Clinical Medical Research and Healthcare Delivery, Vol. 1 [2021], Iss. 2, Art. 11

the patient’s fevers resolved, and his symptoms improved; hence RIPE regimen was continued.
He was discharged with outpatient follow-up at the county health clinic to complete tuberculosis
treatment. Twenty-five days later, Mycobacterium tuberculosis was confirmed on the omental
biopsy tissue cultures though the PCR was inconclusive. He continued to improve till the end of
the 12-month treatment period and tolerated it well with no derangement in liver function tests to
suggest drug hepatotoxicity.

Figure 1. CT scan of the abdomen showing heterogeneous attenuation of the omentum as shown
by the red arrow.
Discussion
Liver cirrhosis is a state of immunosuppression due to reticuloendothelial dysfunction. It is wellestablished that patients with liver cirrhosis are at a higher risk of reactivation of latent tuberculous
bacilli in abdominal macrophages, facilitating the development of tuberculous peritonitis, as seen
in our patient.1 Tuberculosis (TB) can affect any organ in the abdomen but particularly affects the
peritoneum, constituting 31% to 58% of all cases of abdominal tuberculosis.2 Interestingly, in a
study done in the USA, more than 50% of the cases of peritoneal tuberculosis had underlying
alcoholic liver cirrhosis.1
The most common presenting features of tuberculous peritonitis are ascites (71%),
abdominal pain (64.5%), weight loss (61%), and fever (59%), but the classically described doughy
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abdomen associated with tuberculous peritonitis is rarely seen.2 Sometimes it can present as
worsening of liver function or increasing/resistant ascites occurring despite diuretic treatment.3
These are non-specific symptoms that can mimic spontaneous bacterial peritonitis, thus posing a
diagnostic challenge as seen in our patient and a high degree of clinical suspicion is essential to
make a diagnosis of tuberculous peritonitis.
Peritoneal tuberculosis is a paucibacillary disease making it tough to diagnose on routine
AFB stains of ascitic fluid (sensitivity 0% to 40%). PCR, particularly Xpert MTB/RIF, which has
an overall sensitivity of 83.1% to diagnose other types of extrapulmonary tuberculosis, has not
been well studied in ascitic fluid samples for the diagnosis of intra-abdominal tuberculosis.
Laparoscopy with peritoneal/omental biopsies is the investigation of choice to diagnose
tuberculous peritonitis. Tissue from the biopsy should be sent for mycobacterial cultures as well
as routine histopathology. Histopathology typically shows caseating granulomas with Langerhans
giant cells and lymphocytes. 4 In our patient, the first sample omental biopsy sample showed nonnecrotizing granulomas, which has only been reported in a few cases in the medical literature.5,6,7
Unfortunately, the first sample was not sent for mycobacterial tissue cultures prompting a second
CT-guided biopsy to get the tissue sample. The sensitivity of cultures has been reported between
38% and 92%, but it usually takes 2 to 8 weeks for final results, which proves challenging to make
treatment decisions, as with our patient.2,4 Ultimately, since the patient’s clinical condition
continued to decline, the team chose to give an empiric trial of anti-tuberculous drugs even without
final culture data in hand.
There are no concrete guidelines regarding antimycobacterial drugs used in patients with
alcoholic liver cirrhosis. The treatment of tuberculous peritonitis is frequently complicated by poor
drug tolerance, hepatotoxicity, and an increased risk of multidrug resistance. Patients receiving
anti-tuberculous therapy should get a baseline and regular follow-up liver function tests. It is
proposed that anti-tuberculous therapy can be guided by the Child-Turcotte-Pugh score,8 on which
our patient scored 10 i.e., Class C. It is recommended that only one potentially hepatotoxic drug
be used for patients in this category, with rifampicin preferred over isoniazid, while pyrazinamide
should not be used. However, our patient received all four anti-tuberculous drugs and tolerated
them well with no hepatotoxicity on close monitoring. There is some role for the empiric trial of
anti-tuberculous therapy when clinical suspicion for TB is high, as shown by some studies.9
Conclusion
In patients with underlying liver cirrhosis, the diagnosis of peritoneal tuberculosis is often
challenging as it can mimic SBP. Omental tuberculosis should be high on the differential diagnosis
when epidemiological and demographic factors point towards the possibility of TB. Confirming
the diagnosis of tuberculosis by tissue biopsy culture is generally required before subjecting the
patient to the many months of hepatotoxic antitubercular therapy, especially in a patient with liver
cirrhosis. However, in patients who clinically deteriorate and clinical suspicion for tuberculous
peritonitis is high, anti-tuberculous therapy can be potentially started even before the results are
confirmed on tissue cultures, as delayed therapy can worsen clinical outcome.
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